Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Facts and myths about use of esketamine for treatment-resistant depression

A narrative clinical review

Bibliographic Data

ID15522940
AuthorsMatteo Di Vincenzo (0009-0008-3517-8905, University of Campania "Luigi Vanvitelli"), Vassilis Martiadis (0000-0002-3344-1000, ASL Roma), Bianca Della Rocca (0000-0003-0319-400X, University of Campania "Luigi Vanvitelli"), Eleonora Arsenio (University of Campania "Luigi Vanvitelli"), Andrea D’Arpa (University of Campania "Luigi Vanvitelli"), Antonio Volpicelli (University of Campania "Luigi Vanvitelli"), Mario Luciano (0000-0002-4338-1371, University of Campania "Luigi Vanvitelli"), Gaia Sampogna (0000-0002-9547-2793, University of Campania "Luigi Vanvitelli", corresponding author), A Fiorillo (0000-0002-6926-0762, University of Campania "Luigi Vanvitelli")
Year2024
Volume15
Pages1394787-1394787
Publication date2024-05-15
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2024.1394787
PMID38812489
OpenAlexW4396934561
LanguageEN
Citations received6
References cited103

TRD represents a challenging condition, requiring precise diagnosis in order to achieve patient's full recovery. Esketamine has been proved as an effective medication to treat TRD, although it requires precautions. Evidence can inform clinical practice, in order to offer this innovative treatment to all patients with TRD

Art · Cognition · Depression (economics · Literature · Major depressive disorder · Mythology · Narrative · Narrative review · Psychiatry · Psychoanalysis · Psychotherapist · Treatment-resistant depression · Medicine · Mental Health Research Topics · Psychology · Treatment of Major Depression · Tryptophan and brain disorders

  • Case Report

    Open Access•Alexandre Fraichot, Sophie Favre et al.•Frontiers in Psychiatry•2025

  • Suicidality and Aggressive Behaviors in Migrants

    Open Access•Salvatore Cipolla, Bianca Della Rocca et al.•International Journal of Social…•2026

  • The perspectives of patients with depression toward esketamine, and the influence of their medication adherence on their viewpoints

    Open Access•Ahmad H Almadani, Ayedh H Alghamdi et al.•Frontiers in Psychiatry•2025

  • Differential associations of serum globulin and albumin-globulin ratio with depression in cancer and non-cancer populations

    Open Access•Yichen Zan, Cui Guo et al.•Frontiers in Psychiatry•2025

  • Treatment of bipolar depression

    Open Access•Paul Kriner, Peter Brieger et al.•Frontiers in Psychiatry•2024

  • Efficacy and safety of toludesvenlafaxine hydrochloride sustained-release tablets in depression with ineffective or partially effective initial antidepressant treatment

    Open Access•Jingming Yang, Yanyan Jia et al.•Frontiers in Psychiatry•2026

  • Development, Reliability, and Validity of a Dissociation Scale

    EVE M BERNSTEIN, F W Putnam•The Journal of Nervous and Mental…•1986

  • Depression

    Open Access•Gin S Malhi, J John Mann•The Lancet•2018

  • Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps

    A John Rush, Madhukar H Trivedi et al.•American Journal of Psychiatry•2006

  • Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder

    Open Access•Maud Rothärmel, Cherifa Benosman et al.•Frontiers in Psychiatry•2022

  • Case report

    Open Access•Johanna Louise Keeler, Janet Treasure et al.•Frontiers in Psychiatry•2023

  • A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression

    Open Access•Brittany Chubbs, Jay Ching-Chieh Wang et al.•Frontiers in Psychiatry•2022

  • Intranasal Esketamine and Current Suicidal Ideation With Intent in Major Depression Disorder

    Open Access•Maurizio Pompili•Frontiers in Psychiatry•2020

  • The prevalence and economic burden of treatment-resistant depression in Thailand

    Open Access•Jirada Prasartpornsirichoke, Nuttorn Pityaratstian et al.•BMC Public Health•2023

Unique citing works6
Citations per year3
Citation span2024 - 2026 (3)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 6

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae